Reuters logo
Generic drugmakers seek speedy appeal of Maryland price-gouging law
October 5, 2017 / 9:13 PM / in 15 days

Generic drugmakers seek speedy appeal of Maryland price-gouging law

The main trade group for generic pharmaceutical companies has asked a federal appeals court to expedite its challenge to a Maryland law that went into effect on Sunday and is designed to penalize drugmakers for price-gouging.

The Association for Accessible Medicines (AAM) in a brief filed with the 4th U.S. Circuit Court of Appeals in Richmond, Virginia on Wednesday said, absent a speedy appeal, drugmakers will face “certain and irreparable harm” because of the law.

To read the full story on Westlaw Practitioner Insights, click here: bit.ly/2hR0hYG

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below